Figure 3
Figure 3. S typhimurium–NY-ESO-1 activates high-avidity NY-ESO-1–specific CD4+ T-cell precursors from a naive T-cell population (A) CD4+CD25− T cells isolated from PBMCs of NC235 or NW681 were further separated into CD45RA+ or CD45RO+ cells using magnetic beads as described in “Methods.” These T cells were cultured with APCs pulsed with a NY-ESO-1 peptide or infected with S typhimurium–NY-ESO-1. At 15 to 20 days later, specific T-cell elicitation and capacity of elicited NY-ESO-1–specific Th1 cells to recognize naturally processed NY-ESO-1 protein was analyzed by ELISPOT assay using NY-ESO-1 (NC235, NY-ESO-1 157–170; NW681, NY-ESO-1 143–154) or control HIV peptide-pulsed or NY-ESO-1 or SSX-2 protein-pulsed DCs as APCs. (B) Avidity of induced NY-ESO-1–specific Th1 cells was analyzed by ELISPOT assay using T-APCs pulsed with serial dilutions of peptides. These experiments were performed independently at least twice with similar results. Data are expressed as means plus or minus SD.

S typhimurium–NY-ESO-1 activates high-avidity NY-ESO-1–specific CD4+ T-cell precursors from a naive T-cell population (A) CD4+CD25 T cells isolated from PBMCs of NC235 or NW681 were further separated into CD45RA+ or CD45RO+ cells using magnetic beads as described in “Methods.” These T cells were cultured with APCs pulsed with a NY-ESO-1 peptide or infected with S typhimurium–NY-ESO-1. At 15 to 20 days later, specific T-cell elicitation and capacity of elicited NY-ESO-1–specific Th1 cells to recognize naturally processed NY-ESO-1 protein was analyzed by ELISPOT assay using NY-ESO-1 (NC235, NY-ESO-1 157–170; NW681, NY-ESO-1 143–154) or control HIV peptide-pulsed or NY-ESO-1 or SSX-2 protein-pulsed DCs as APCs. (B) Avidity of induced NY-ESO-1–specific Th1 cells was analyzed by ELISPOT assay using T-APCs pulsed with serial dilutions of peptides. These experiments were performed independently at least twice with similar results. Data are expressed as means plus or minus SD.

Close Modal

or Create an Account

Close Modal
Close Modal